Every FDA drug enforcement report from the last 90 days - recalling firm, reason for recall and severity classification. Includes recalls affecting Irish-manufactured products distributed in the US market.
| Reported | Class | Product | Recalling Firm |
|---|---|---|---|
| 01 Jul 2026 | Class II | LACOSAMIDE
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets… |
Annora Pharma Private Limited |
| 01 Jul 2026 | Class II | CORLANOR
Presence of Foreign Substance. |
Amgen, Inc. |
| 01 Jul 2026 | Class II | CORLANOR
Presence of Foreign Substance. |
Amgen, Inc. |
| 01 Jul 2026 | Class II | CHLORAPREP ONE-STEP
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area. |
CareFusion 213, LLC |
| 01 Jul 2026 | Class II | FENOFIBRATE
CGMP Deviations |
Ajanta Pharma USA Inc |
| 01 Jul 2026 | Class II | SENSIPAR
CGMP Deviations |
Amgen, Inc. |
| 01 Jul 2026 | Class II | POVI-ONE
sub potency |
Elevate Oral Care |
| 01 Jul 2026 | Class II | DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30…
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit |
Direct Rx |
| 01 Jul 2026 | Class II | CHLORAPREP ONE-STEP
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area. |
CareFusion 213, LLC |
| 01 Jul 2026 | Class II | Total Parental Nutrition - Pediatric PN Patient-Specific TP…
Incorrect product formulation: bag did not contain copper and famotidine per label. |
Central Admixture Pharmacy Services, Inc. |
| 01 Jul 2026 | Class II | METHYLERGONOVINE MALEATE
Subpotent Drug |
The Harvard Drug Group LLC |
| 01 Jul 2026 | Class II | PReye Vitamin See Antioxidant Preservative Free Eye Drops, …
Lack of Assurance of Sterility |
PReye LLC |
| 01 Jul 2026 | Class I | CHLORAPREP ONE-STEP
Non-Sterility: Due to presence of Aspergillus penicillioides. |
CareFusion 213, LLC |
| 01 Jul 2026 | Class III | HYDROXYZINE HYDROCHLORIDE
Presence of foreign substance |
ANI Pharmaceuticals, Inc. |
| 01 Jul 2026 | Class II | PERAMPANEL
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets. |
SUN PHARMACEUTICAL INDUSTRIES INC |
| 01 Jul 2026 | Class II | SENSIPAR
CGMP Deviations |
Amgen, Inc. |
| 01 Jul 2026 | Class II | SENSIPAR
CGMP Deviations |
Amgen, Inc. |
| 01 Jul 2026 | Class I | CHLORAPREP ONE-STEP
Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper li… |
CareFusion 213, LLC |
| 24 Jun 2026 | Class II | HEALTH-TEC TOPICAL ANESTHETIC
Defective container:may contain bottles with incomplete seals |
Keystone Industries |
| 24 Jun 2026 | Class II | Med Pride, HYDROCORTISONE CREAM 1%, Net Wt. 1 oz (28.3g) tu…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | PURELIFE TOPICAL ANESTHETIC
Defective container:may contain bottles with incomplete seals |
Keystone Industries |
| 24 Jun 2026 | Class II | Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Z…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc (equ…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | Lucky Super Soft, First Aid Triple Antibiotic Ointment, Bac…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | Med Pride, Bacitracin Zinc Ointment, 1oz (28.3g) per tube, …
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, …
Subpotent Drug |
IntegraDose Compounding Services LLC |
| 24 Jun 2026 | Class II | CHLORTHALIDONE
Failed Dissolution Specifications |
Inventia Healthcare Limited |
| 24 Jun 2026 | Class II | QUALA TOPICAL ANESTHETIC GEL
Defective container:may contain bottles with incomplete seals |
Keystone Industries |
| 24 Jun 2026 | Class II | Lucky Super Soft, Antifungal Athlete's Foot Cream, Clotrima…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | Med Pride, HYDROCORTISONE CREAM 1%, Net Wt. 16oz (454g) tub…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | Med Pride, Bacitracin Zinc Ointment, 500 units, 1oz (28.3g)…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY …
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 |
PAI Holdings LLC |
| 24 Jun 2026 | Class II | VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY…
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 |
PAI Holdings LLC |
| 24 Jun 2026 | Class II | VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY …
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 |
PAI Holdings LLC |
| 24 Jun 2026 | Class II | ARIPIPRAZOLE
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. |
Ajanta Pharma USA Inc |
| 24 Jun 2026 | Class II | BURKHART TOPICAL ANESTHETIC
Defective container:may contain bottles with incomplete seals |
Keystone Industries |
| 24 Jun 2026 | Class II | DENTAL CITY TOPICAL ANESTHETIC
Defective container:may contain bottles with incomplete seals |
Keystone Industries |
| 24 Jun 2026 | Class II | Lil Drug Store, Triple Antibiotic Ointment, Bacitracin Zinc…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | SAFCO SENSICAINE ULTRA TOPICAL ANESTHETIC GEL
Defective container:may contain bottles with incomplete seals |
Keystone Industries |
| 24 Jun 2026 | Class II | Med Pride, 1% Clotrimazole Antifungal Cream, Net Wt. 1oz (2…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class III | FOCALIN
Labeling: Incorrect or Missing Lot and/or Exp Date |
Sandoz Inc |
| 24 Jun 2026 | Class II | Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc 400 …
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | ALYACEN 1/35
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities. |
Glenmark Pharmaceuticals Inc., USA |
| 24 Jun 2026 | Class II | Circle K, triple antibiotic ointment, Bacitracin Zinc (400 …
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | BUPRENORPHINE HYDROCHLORIDE
Crystallization; identified as Buprenorphine free base |
Par Health USA, LLC |
| 24 Jun 2026 | Class II | PEARSON TOPICAL ANESTHETIC
Defective container:may contain bottles with incomplete seals |
Keystone Industries |
| 24 Jun 2026 | Class II | VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY…
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023 |
PAI Holdings LLC |
| 24 Jun 2026 | Class II | Cura Hongos, Crema Antifungica, Clotrimazole 1%, 2oz (57g) …
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 24 Jun 2026 | Class II | Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packet…
CGMP Deviations; deficiencies observed during FDA inspection |
Dabur India Limited |
| 17 Jun 2026 | Class II | MINOCYCLINE HYDROCHLORIDE
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test ana… |
Ascend Laboratories, LLC |
| 17 Jun 2026 | Class I | Gas-X Extra Strength, SIMETHICONE 125 mg/ANTIGAS, packaged …
Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging p… |
Haleon US Holdings LLC |
| 17 Jun 2026 | Class I | BEEKEEPER'S NATURALS Saline Nasal Spray, Sinus Congestion R…
Microbial Contamination of Non-Sterile Products |
BEEKEEPER'S NATURALS USA INC. |
| 17 Jun 2026 | Class II | BUDESONIDE
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown … |
SUN PHARMACEUTICAL INDUSTRIES INC |
| 17 Jun 2026 | Class II | ZEP ALCOHOL SANITIZER
Microbial contamination of sterile products |
Zep Inc |
| 17 Jun 2026 | Class II | DULOXETINE
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit |
Breckenridge Pharmaceutical, Inc. |
| 17 Jun 2026 | Class III | EPINEPHRINE
Failed Impurities/Degradations Specifications |
Fresenius Kabi USA, LLC |
| 17 Jun 2026 | Class I | DOXORUBICIN HYDROCHLORIDE
Presence of Particulate matter: Particulate matter identified as glass. |
SUN PHARMACEUTICAL INDUSTRIES INC |
| 17 Jun 2026 | Class II | DULOXETINE
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit |
Breckenridge Pharmaceutical, Inc. |
| 17 Jun 2026 | Class III | PRIMIDONE
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the AP… |
Amneal Pharmaceuticals, LLC |
| 17 Jun 2026 | Class II | NIACIN
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for st… |
Golden State Medical Supply Inc. |
| 10 Jun 2026 | Class II | HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Table…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | LIDOCAINE HYDROCHLORIDE
Lack of Assurance of Sterility |
Spectra Medical Devices, Llc |
| 10 Jun 2026 | Class II | HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 7…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | EXTRA STRENGTH ANTACID
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | HyVee, Extra Strength Antacid, Calcium Carbonate 750 mg, 96…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class III | LIDOLOG KIT
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan |
Eugia US LLC |
| 10 Jun 2026 | Class II | TOPCARE ULTRA STRENGTH ANTACID ASSORTED FRUIT
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | GOODSENSE ULTRA STRENGTH ANTACID ASSORTED FRUIT
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Table…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | DISCOUNT drug mart, EXTRA STRENGTH, ANTACID TABLETS, Calciu…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | ULTRA STRENGTH ANTACID ASSORTED BERRIES
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | EQU ULTRA STRENGTH ANTACID ASSORTED FRUIT 171AF
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | GOODSENSE EXTRA STRENGTH ANTACID
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | EQUALINE EXTRA STRENGTH ASSORTED BERRY ANTACID
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | ULTRA STRENGTH ANTACID ASSORTED FRUIT
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx…
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product unde… |
SUN PHARMACEUTICAL INDUSTRIES INC |
| 10 Jun 2026 | Class II | Extra strength Antacid Calcium Carbonate 750 mg, chewable t…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | AMLODIPINE AND OLMESARTAN MEDOXOMIL
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications |
Ascend Laboratories, LLC |
| 10 Jun 2026 | Class II | DULOXETINE
CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable … |
Asclemed USA Inc. |
| 10 Jun 2026 | Class II | TOPCARE EXTRA STRENGTH ANTACID
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | FAMILY WELLNESS ULTRA STRENGTH ASSORTED FRUIT ANTACID
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | MARKET BASKET ANTACID Calcium Carbonate 1000 mg, ULTRA STRE…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | 24/7 life BY 7-ELEVEN, Extra strength Antacid Tablets, Calc…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | HEB EXTRA STREGTH ANTACID
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | Harris Teeter, ULTRA STRENGTH ANTACID, Calcium Carbonate 10…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | Xyvona (levorphanol tartrate tablets), 3mg, 100 Tablets, Rx…
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product unde… |
SUN PHARMACEUTICAL INDUSTRIES INC |
| 10 Jun 2026 | Class II | GOOD NEIGHBOR PHARMACY ANTACID
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | NIACIN
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint. |
Lannett Company Inc. |
| 10 Jun 2026 | Class II | FAMILY WELLNESS, ULTRA STRENGT, ANTACID TABLETS, Calcium Ca…
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 10 Jun 2026 | Class II | KIRKLAND ULTRA STREGTH ANTACID 171AB
Presence of foreign substance: small metallic particles in chewable tablets. |
Guardian Drug Co. Inc. |
| 03 Jun 2026 | Class III | NICOTINE
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specification… |
AVEVA Drug Delivery Systems, Inc. |
| 03 Jun 2026 | Class III | PRED MILD
Failed Stability Specifications |
AbbVie Inc. |
| 27 May 2026 | Class II | ATOMOXETINE
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule. |
Safecor Health, LLC |
| 27 May 2026 | Class II | fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50…
Subpotent Drug |
IntegraDose Compounding Services LLC |
| 27 May 2026 | Class II | ERYTHROMYCIN
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit |
Zydus Pharmaceuticals (USA) Inc |
| 27 May 2026 | Class II | LIRAGLUTIDE
Presence of particulate matter: a white thread-like structure in the cartridge |
Lupin Pharmaceuticals Inc. |
| 27 May 2026 | Class II | ERYTHROMYCIN
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit |
Zydus Pharmaceuticals (USA) Inc |
| 27 May 2026 | Class III | PRIMIDONE
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. |
Amerisource Health Services LLC |
| 27 May 2026 | Class III | PRIMIDONE
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. |
Golden State Medical Supply Inc. |
| 27 May 2026 | Class III | PRIMIDONE
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. |
Golden State Medical Supply Inc. |
Source: openFDA Drug Enforcement API, U.S. Food & Drug Administration - Class I is the most serious (reasonable probability of serious harm or death), Class III the least. openFDA data is provided as-is and unvalidated. See our FDA Approvals Tracker for new drug approvals, or the EMA Approvals Tracker for the EU market.